Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
PENTOBARBITAL SODIUM
Merial Animal Health Limited
QN51AA01
PENTOBARBITAL SODIUM
200 Mg/Ml
Solution for Injection
VPO-Vet.Practitioner Only
Canine, Feline, Non Food Animals
Pentobarbital
Neurological Preparations
Authorised
1995-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT EUTHATAL solution for injection 200 mg in 1 ml. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Blue aqueous solution for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats and other small animals. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Euthanasia in dogs, cats and other small animals. 4.3 CONTRAINDICATIONS Do not use for anaesthetic purposes. Carcasses of animals, which have been euthanased with the product, must not be used for animal consumption. Do not administer by intramuscular route. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES In some circumstances the intrathoracic or intracardiac routes of administration may be used, but only as a last resort. The choice of these routes should be made in the light of the attendant difficulties and the unnecessary pain and distress to the animal which could result. When it is anticipated that euthanasia may be problematical (e.g. aggressive patients), premedication with appropriate sedative is recommended. Each ml contains: ACTIVE SUBSTANCE Pentobarbital sodium 200 mg EXCIPIENTS Patent Blue V (E131) 0.01 mg For full list of excipients, see section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 11/05/2015_ _CRN 7020801_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS In the event of accidental administration to an animal not presented for euthanasia, measures such as artificial respiration, administration of oxygen, and the use of analeptics are appropriate. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In the case of a Lue koko asiakirja